James Investment Research Inc Abb Vie Inc. Transaction History

James Investment Research Inc

$853 Million
Q3 2024

A detailed history of James Investment Research Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, James Investment Research Inc holds 38,093 shares of ABBV stock, worth $6.46 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares

38,093

Previous 38,985 2.29%

Holding current value

$6.46 Million

Previous $6.69 Million 12.5%

% of portfolio

0.88%

Previous 0.81%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$163.84 - $199.33 $146,145 - $177,802	-892 Reduced 2.29%	38,093 $7.52 Million
Q2 2024 Jul 30, 2024	SELL	$154.79 - $180.76 $31,731 - $37,055	-205 Reduced 0.52%	38,985 $6.69 Million
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $232,378 - $264,773	-1,454 Reduced 3.58%	39,190 $7.14 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $213,968 - $240,978	-1,555 Reduced 3.68%	40,644 $6.3 Million
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $72,539 - $83,974	-543 Reduced 1.27%	42,199 $6.29 Million
Q2 2023 Aug 07, 2023	BUY	$132.51 - $164.9 $5.66 Million - $7.05 Million	42,742 New	42,742 $5.76 Million
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $295,438 - $340,241	2,043 Added 4.97%	43,169 $6.88 Million
Q4 2022 Jan 30, 2023	BUY	$138.31 - $165.87 $310,920 - $372,875	2,248 Added 5.78%	41,126 $6.65 Million
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $2.02 Million - $2.31 Million	15,019 Added 62.95%	38,878 $5.22 Million
Q2 2022 Aug 01, 2022	BUY	$137.62 - $174.96 $24,083 - $30,618	175 Added 0.74%	23,859 $3.65 Million
Q1 2022 Apr 22, 2022	SELL	$131.98 - $163.75 $292,071 - $362,378	-2,213 Reduced 8.55%	23,684 $3.84 Million
Q4 2021 Jan 28, 2022	BUY	$107.43 - $135.93 $13,106 - $16,583	122 Added 0.47%	25,897 $3.51 Million
Q3 2021 Oct 22, 2021	BUY	$106.4 - $120.78 $56,924 - $64,617	535 Added 2.12%	25,775 $2.78 Million
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $255,660 - $284,820	2,430 Added 10.65%	25,240 $2.84 Million
Q1 2021 Apr 22, 2021	BUY	$102.3 - $112.62 $2.3 Million - $2.53 Million	22,472 Added 6648.52%	22,810 $2.47 Million
Q4 2020 Jan 27, 2021	SELL	$80.49 - $108.67 $2,495 - $3,368	-31 Reduced 8.4%	338 $36,000
Q3 2020 Oct 23, 2020	BUY	$85.91 - $100.83 $31,700 - $37,206	369 New	369 $32,000
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $9,329 - $11,925	-142 Closed	0 $0
Q1 2019 Apr 26, 2019	SELL	$77.14 - $90.79 $954,761 - $1.12 Million	-12,377 Reduced 98.87%	142 $11,000
Q4 2018 Jan 22, 2019	BUY	$77.85 - $96.01 $974,604 - $1.2 Million	12,519 New	12,519 $1.15 Million
Q3 2018 Oct 26, 2018	SELL	$88.91 - $98.84 $1.74 Million - $1.94 Million	-19,605 Closed	0 $0
Q2 2018 Jul 19, 2018	BUY	$89.78 - $106.23 $224,898 - $266,106	2,505 Added 14.65%	19,605 $1.82 Million
Q1 2018 Apr 12, 2018	SELL	$92.01 - $123.21 $82,809 - $110,889	-900 Reduced 5.0%	17,100 $1.62 Million
Q4 2017 Jan 23, 2018	BUY	$89.56 - $98.21 $1.61 Million - $1.77 Million	18,000	18,000 $1.74 Million

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.

Account

James Investment Research Inc Abb Vie Inc. Transaction History